BENEFIX (recombinant factor IX) Patient Assistance Program
Don’t let the high cost of brand factor IX replacement disrupt your hemophilia B treatment. We help eligible patients access BeneFIX (recombinant factor IX) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- BeneFIX (coagulation factor IX, recombinant, nonacog alfa) is FDA-approved for control and prevention of bleeding in adults and children with hemophilia B, perioperative management, and routine prophylaxis. Standard half-life recombinant factor IX given by IV infusion.
- Without assistance, BeneFIX costs commonly run approximately $20,000–$50,000+ per month depending on prophylaxis dose and patient weight.
- Through AffordMyPrescriptions, qualifying patients can access BeneFIX for a flat $69.95 per month.
- Other recombinant factor IX products: Alprolix (rFIXFc — extended half-life, less frequent dosing), Rebinyn (rFIX with site-directed PEGylation — even longer half-life), Idelvion (rIX-FP — also extended half-life). Plasma-derived FIX also available (AlphaNine SD, Mononine). Gene therapy: Hemgenix and Beqvez (one-time treatments for severe hemophilia B — ~$3.5 million but potentially curative).
What Is BeneFIX Prescription Assistance Program?
BeneFIX PAP for hemophilia B patients.
Eligibility, hematology coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- BeneFIX $20,000–$50,000+/month. PAP critical for affordability:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Specialty Pharmacy | ~$30,000+ | Save substantially |
| Hospital pharmacy | ~$50,000+ | Save substantially |
| Extended half-life products | ~$25,000+ | Less frequent dosing |
| PAP-approved | $0 | Manufacturer PAP |
Hemophilia Foundation | Resources | Aid |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your BeneFIX Prescription Program?
PAP critical at this price. Annual cost commonly $250,000–$600,000+. Extended half-life products (Alprolix, Rebinyn, Idelvion) more convenient. Gene therapy options (Hemgenix, Beqvez) potentially curative.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for BeneFIX:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $20,000–$50,000+ per month per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for BeneFIX assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid BeneFIX Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding BeneFIX :
BeneFIX is recombinant factor IX for hemophilia B (factor IX deficiency). Hemophilia B is X-linked recessive bleeding disorder caused by F9 gene mutations — affects ~1:25,000 males. Without treatment, recurrent joint bleeds cause arthropathy; CNS bleeds can be fatal. Modern prophylaxis dramatically improves outcomes.
How BeneFIX Works:
Factor IX is essential clotting factor in intrinsic coagulation pathway — activates factor X to form thrombin. Deficiency causes prolonged bleeding.
BeneFIX is recombinant FIX produced in CHO cells — standard half-life (~18–24 hours), so requires twice-weekly IV infusion for prophylaxis. Extended half-life products (rFIXFc, rIX-FP, rFIX-PEGylated) allow weekly or less frequent dosing. Prophylaxis prevents joint bleeds and complications; episodic use for acute bleeds.
Form and use:
BeneFIX IV infusion. Prophylaxis: dose every 3–4 days (or twice weekly). Treatment: dose calculated by bleed severity and target factor level. Self-infused at home after training. Tracked via factor logs.
Generic availability:
No biosimilar. Other FIX products: Alprolix (rFIXFc — extended half-life, weekly), Rebinyn (rFIX-PEGylated), Idelvion (rIX-FP, weekly–every-2-weeks). Plasma-derived: AlphaNine SD, Mononine. Hemgenix (etranacogene dezaparvovec) and Beqvez (fidanacogene elaparvovec) — gene therapies as one-time treatments for severe hemophilia B (~$3.5 million but durable factor production).
Warnings:
Hypersensitivity reactions and anaphylaxis (especially in patients with prior allergic reactions to factor IX); inhibitor development (anti-FIX antibodies — less common than factor VIII inhibitors but possible; reduces factor activity, may cause severe allergic reactions); thrombotic events (especially with bypassing agents); nephrotic syndrome (in patients with FIX inhibitors and history of allergic reactions).
FAQ (Frequently Asked Questions)
Cost?
$20,000–$50,000+/month. Annual $250,000–$600,000+. Manufacturer PAP critical for uninsured/underinsured. Insurance typically covers hemophilia treatment but high copays/deductibles common.$20,000–$50,000+/month. Annual $250,000–$600,000+. Manufacturer PAP critical for uninsured/underinsured. Insurance typically covers hemophilia treatment but high copays/deductibles common.
BeneFIX vs extended half-life FIX?
BeneFIX (standard half-life): every 3–4 days IV infusion. Alprolix/Rebinyn/Idelvion (extended half-life): weekly or less frequent dosing. Trade-offs: convenience vs cost vs personal response. Many hemophilia B patients have switched to extended half-life products for convenience.
Gene therapy?
Hemgenix and Beqvez are FDA-approved one-time IV gene therapies for severe hemophilia B in eligible adults. AAV vector delivers F9 gene to liver — produces functional factor IX. Cost ~$3.5 million but potentially eliminates need for ongoing factor replacement. Available at specialized centers.
Inhibitor development??
Anti-FIX antibodies less common than anti-FVIII (hemophilia A inhibitors) — affect ~3–5% of hemophilia B patients, often with severe allergic reactions to FIX. Inhibitor management complex; may require bypassing agents (FEIBA, NovoSeven), immune tolerance, or gene therapy.
Home infusion?
Standard for hemophilia care. Patient/family trained for self-infusion. Infusion log critical for tracking dose, response, breakthrough bleeds. Hemophilia treatment centers coordinate.
Denied?
Other FIX products with own PAPs. Hemophilia Federation of America, National Hemophilia Foundation, PAN Foundation. Gene therapy referral for severe disease.
Take Control of Your Medication Costs
If struggling with BeneFIX cost, manufacturer PAP and hemophilia foundations are critical. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.